These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7567696)

  • 21. PSA forms complexes with α1-antichymotrypsin in prostate.
    Zhu L; Jäämaa S; Af Hällström TM; Laiho M; Sankila A; Nordling S; Stenman UH; Koistinen H
    Prostate; 2013 Jan; 73(2):219-26. PubMed ID: 22806587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.
    Christensson A; Laurell CB; Lilja H
    Eur J Biochem; 1990 Dec; 194(3):755-63. PubMed ID: 1702714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implications.
    Jung K; Brux B; Lein M; Rudolph B; Kristiansen G; Hauptmann S; Schnorr D; Loening SA; Sinha P
    Clin Chem; 2000 Jan; 46(1):47-54. PubMed ID: 10620571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate specific antigen complexed to alpha-1-antichymotrypsin in patients with intermediate prostate specific antigen levels.
    Saika T; Tsushima T; Nasu Y; Kusaka N; Miyaji Y; Takamoto H; Takeda K; Uno S; Kumon H;
    Cancer; 2002 Mar; 94(6):1685-91. PubMed ID: 11920529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia.
    Björk T; Bjartell A; Abrahamsson PA; Hulkko S; di Sant'Agnese A; Lilja H
    Urology; 1994 Apr; 43(4):427-34. PubMed ID: 7512295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Concentrations of free form and complex form of prostate-specific antigen in serum of alpha 2 macroglobulin deficient patients with prostatic carcinoma].
    Kanoh Y; Jimbo S; Shibuya M; Matsuyama N; Mashiko T; Tanaka T; Egawa S; Ohtani H
    Rinsho Byori; 1998 Sep; 46(9):923-9. PubMed ID: 9800478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the enzymatic activity of prostate-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer.
    Lilja H
    Scand J Clin Lab Invest Suppl; 1995; 220():47-56. PubMed ID: 7544478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to alpha 1-antichymotrypsin.
    Lilja H
    Urol Clin North Am; 1993 Nov; 20(4):681-6. PubMed ID: 7505976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: implications for point-of-care testing.
    Piironen T; Nurmi M; Irjala K; Heinonen O; Lilja H; Lövgren T; Pettersson K
    Clin Chem; 2001 Apr; 47(4):703-11. PubMed ID: 11274021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-label time-resolved immunofluorometric assay of prostate-specific antigen and of its complex with alpha 1-antichymotrypsin.
    Leinonen J; Lövgren T; Vornanen T; Stenman UH
    Clin Chem; 1993 Oct; 39(10):2098-103. PubMed ID: 7691441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology.
    Roehrborn CG; Gregory A; McConnell JD; Sagalowsky AI; Wians FH
    Urology; 1996 Dec; 48(6A Suppl):23-32. PubMed ID: 8973696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic significance of prostate-specific antigen velocity at intermediate PSA serum levels in relation to the standard deviation of different test systems.
    Manseck A; Pilarsky C; Froschermaier S; Menschikowski M; Wirth MP
    Urol Int; 1998; 60(1):25-7. PubMed ID: 9519417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-dimensional gel electrophoresis detects prostate-specific antigen-alpha1-antichymotrypsin complex in serum but not in prostatic fluid.
    Qian Y; Sensibar JA; Zelner DJ; Schaeffer AJ; Finlay JA; Rittenhouse HG; Lee C
    Clin Chem; 1997 Feb; 43(2):352-9. PubMed ID: 9023139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epithelium.
    Bjartell A; Björk T; Matikainen MT; Abrahamsson PA; di Sant'Agnese A; Lilja H
    Urology; 1993 Nov; 42(5):502-10. PubMed ID: 7694414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal evaluation of the complexed-to-total prostate specific antigen ratio in men with prostate disease. Effect of treatment.
    España F; Martínez M; Royo M; Vera CD; Estellés A; Aznar J; Jiménez-Cruz JF
    Eur J Cancer; 1998 Aug; 34(9):1375-80. PubMed ID: 9849420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution and secretory pathways of prostate specific antigen, alpha1-antichymotrypsin and prostate secretory granules in prostate cancers.
    Ishida E; Nakamura M; Shimada K; Kishi M; Nakaoka S; Konishi N
    Pathol Int; 2003 Jul; 53(7):415-21. PubMed ID: 12828605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of serum concentrations of PSA-ACT complex with total PSA in random and serial specimens from patients with BPH and prostate cancer.
    Wu JT; Wilson L; Zhang P; Meikle AW; Stephenson R
    J Clin Lab Anal; 1995; 9(1):15-24. PubMed ID: 7536835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen.
    Denmeade SR; Lou W; Lövgren J; Malm J; Lilja H; Isaacs JT
    Cancer Res; 1997 Nov; 57(21):4924-30. PubMed ID: 9354459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate-specific antigen forms a complex with and cleaves alpha 1-protease inhibitor in vitro.
    Zhang WM; Leinonen J; Kalkkinen N; Stenman UH
    Prostate; 1997 Oct; 33(2):87-96. PubMed ID: 9316649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.